Juan Torres‐Macho

2.6k total citations · 1 hit paper
67 papers, 1.0k citations indexed

About

Juan Torres‐Macho is a scholar working on Infectious Diseases, Neurology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Juan Torres‐Macho has authored 67 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 26 papers in Neurology and 15 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Juan Torres‐Macho's work include COVID-19 Clinical Research Studies (26 papers), Long-Term Effects of COVID-19 (26 papers) and COVID-19 and Mental Health (13 papers). Juan Torres‐Macho is often cited by papers focused on COVID-19 Clinical Research Studies (26 papers), Long-Term Effects of COVID-19 (26 papers) and COVID-19 and Mental Health (13 papers). Juan Torres‐Macho collaborates with scholars based in Spain, Denmark and United States. Juan Torres‐Macho's co-authors include César Fernández‐de‐las‐Peñas, Valentín Hernández‐Barrera, Lars Arendt‐Nielsen, Pablo Ryan, Carlos Guijarro, Jacqueline Veronica Velasco, Kin Israel Notarte, Óscar J. Pellicer-Valero, José D. Martín‐Guerrero and Brandon Michael Henry and has published in prestigious journals such as Diabetes, Pain and The Journals of Gerontology Series A.

In The Last Decade

Juan Torres‐Macho

64 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature

2022 114 citations César Fernández‐de‐las‐Peñas, Kin Israel Notarte et al. Viruses profile →

Peers

Countries citing papers authored by Juan Torres‐Macho

Since Specialization

Citations

This map shows the geographic impact of Juan Torres‐Macho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Torres‐Macho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Torres‐Macho more than expected).

Fields of papers citing papers by Juan Torres‐Macho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Torres‐Macho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Torres‐Macho. The network helps show where Juan Torres‐Macho may publish in the future.

Co-authorship network of co-authors of Juan Torres‐Macho

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Torres‐Macho. A scholar is included among the top collaborators of Juan Torres‐Macho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Torres‐Macho. Juan Torres‐Macho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Riesgo de tromboembolia venosa en población transgénero en terapia hormonal: una revisión sistemática y metaanálisis 2025 ·Medicina Clínica ·Anabel Franco‐Moreno, (unknown), Nuria Muñoz‐Rivas, (unknown), Juan Torres‐Macho, (unknown)	1
2	External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study 2024 ·Clinical & Translational Oncology ·Anabel Franco‐Moreno, (unknown), (unknown), (unknown), Nuria Muñoz‐Rivas, Ana Isabel Farfán‐Sedano, (unknown), Juan Torres‐Macho, (unknown), (unknown), José Manuel Ruiz‐Giardín, (unknown)	3
3	Correction: Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review 2024 ·Infection ·César Fernández‐de‐las‐Peñas, Juan Torres‐Macho, Jesus Alfonso Catahay, (unknown), Jacqueline Veronica Velasco, (unknown), Mario Caldararo, Brandon Michael Henry, Giuseppe Lippi, Anabel Franco‐Moreno, Kin Israel Notarte	1
4	Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study 2024 ·Journal of Medical Virology ·César Fernández‐de‐las‐Peñas, Juan Torres‐Macho, María Ruiz‐Ruigómez, (unknown), (unknown), (unknown), (unknown), Pablo Ryan, Carlos Lumbreras, Óscar J. Pellicer-Valero, Rocco Giordano, Lars Arendt‐Nielsen, Anabel Franco‐Moreno	5
5	Inflammatory Polymorphisms (IL-6 rs1800796, IL-10 rs1800896, TNF-α rs1800629, and IFITM3 rs12252) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 Survivors 2024 ·Viruses ·César Fernández‐de‐las‐Peñas, Gema Dı́az-Gil, (unknown), (unknown), Silvia Ambite‐Quesada, Juan Torres‐Macho, Pablo Ryan, Anabel Franco‐Moreno, Óscar J. Pellicer-Valero, Lars Arendt‐Nielsen, Rocco Giordano	3
6	DNA Methylation Levels of the ACE2 Promoter Are Not Associated with Post-COVID-19 Symptoms in Individuals Who Had Been Hospitalized Due to COVID-19 2024 ·Microorganisms ·César Fernández‐de‐las‐Peñas, Gema Dı́az-Gil, (unknown), (unknown), Silvia Ambite‐Quesada, Juan Torres‐Macho, Pablo Ryan, Anabel Franco‐Moreno, Óscar J. Pellicer-Valero, Lars Arendt‐Nielsen, Rocco Giordano	0
7	Immune response against the SARS-CoV-2 spike protein in cancer patients after COVID-19 vaccination during the Omicron wave: a prospective study 2024 ·Journal of Infection and Public Health ·(unknown), Pablo Ryan, (unknown), María Martin‐Vicente, Guillermo Cuevas, Jorge Valencia, Eva Jiménez, Natalia Blanca‐López, (unknown), José‐Ángel Hernández‐Rivas, (unknown), Vicente Más, Daniel Sepúlveda‐Crespo, Mónica Vázquez, Juan Torres‐Macho, Isidoro Martínez, Salvador Resino	3
8	Principales aplicaciones de la ecografía clínica en cuidados paliativos 2023 ·Revista Clínica Española ·(unknown), Luis M. Beltrán, (unknown), (unknown), (unknown), (unknown), Juan Torres‐Macho	2
9	Prediction of Venous Thromboembolism in Patients With Cancer Using Machine Learning Approaches: A Systematic Review and Meta-Analysis 2023 ·JCO Clinical Cancer Informatics ·Anabel Franco‐Moreno, (unknown), Nuria Muñoz‐Rivas, Juan Torres‐Macho, José Manuel Ruiz‐Giardín, (unknown)	9
10	Serological Biomarkers at Hospital Admission and Hospitalization Treatments Are Not Related to Sensitization-Associated Symptoms in Patients with Post-COVID Pain 2023 ·Pathogens ·César Fernández‐de‐las‐Peñas, Carlos Guijarro, Juan Torres‐Macho, Óscar J. Pellicer-Valero, Anabel Franco‐Moreno, Jo Nijs, María Velasco	1
11	Trajectory of Gastrointestinal Symptoms in Previously Hospitalized COVID-19 Survivors: The Long COVID Experience Multicenter Study 2023 ·Viruses ·César Fernández‐de‐las‐Peñas, Juan Torres‐Macho, Carlos Guijarro, José D. Martín‐Guerrero, Óscar J. Pellicer-Valero, Gustavo Plaza‐Manzano	6
12	Clinical prediction model for pulmonary thrombosis diagnosis in hospitalized patients with SARS-CoV-2 infection 2023 ·Journal of Clinical and Translational Research ·Anabel Franco‐Moreno, (unknown), (unknown), (unknown), (unknown), (unknown), Nuria Muñoz‐Rivas, (unknown), José Manuel Ruiz‐Giardín, (unknown), (unknown), (unknown), Juan Torres‐Macho, (unknown)	1
13	Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial 2022 ·Journal of Clinical Medicine ·Nuria Muñoz‐Rivas, Jesús Aibar, (unknown), (unknown), (unknown), Vicente Gómez del Olmo, Pablo Demelo‐Rodríguez, (unknown), Pau Bosch‐Nicolau, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Edelmira Martí, (unknown), Manuel Méndez‐Bailón, José‐Ángel Hernández‐Rivas, Juan Torres‐Macho	13
14	HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study 2021 ·International Journal of Drug Policy ·Pablo Ryan, Jorge Valencia, Guillermo Cuevas, Jesús Troya, (unknown), Antonio Rodríguez, Juan Torres‐Macho, (unknown), (unknown), Sonia Vázquez‐Morón, Salvador Resino	16
15	Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain 2021 ·Journal of Clinical Immunology ·Jesús Troya, Paul Bastard, Laura Planas‐Serra, Pablo Ryan, Montserrat Ruíz, (unknown), Juan Torres‐Macho, (unknown), Laurent Abel, Jean‐Laurent Casanova, Aurora Pujol	71
16	Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care 2021 ·Liver International ·Jorge Valencia, Jeffrey V. Lazarus, Francisco C. Ceballos, Jesús Troya, Guillermo Cuevas, Salvador Resino, Juan Torres‐Macho, Pablo Ryan	11
17	Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain 2021 ·Open Forum Infectious Diseases ·Jorge Valencia, Jesús Troya, Jeffrey V. Lazarus, Guillermo Cuevas, Alejandro Álvaro‐Meca, Juan Torres‐Macho, (unknown), David Lozano‐Paniagua, Santiago Moreno, Pablo Ryan	1
18	The PANDEMYC Score. An Easily Applicable and Interpretable Model for Predicting Mortality Associated With COVID-19 2020 ·Journal of Clinical Medicine ·Juan Torres‐Macho, Pablo Ryan, Jorge Valencia, Mario Pérez, Eva Jiménez, Mario Fontán‐Vela, Elsa Izquierdo-García, (unknown), (unknown), (unknown), (unknown), (unknown), Salvador Resino, (unknown), Alejandro Álvaro‐Meca	32
19	Aortic thrombus in patients with severe COVID-19: review of three cases 2020 ·Journal of Thrombosis and Thrombolysis ·(unknown), (unknown), Jesús Troya, Roberto Alcázar Arroyo, Cristina García-De la Peña, (unknown), (unknown), Juan Torres‐Macho, Nuria Muñoz‐Rivas	29
20	Point-of-care ultrasound in internal medicine: A position paper by the ultrasound working group of the European federation of internal medicine 2019 ·European Journal of Internal Medicine ·Juan Torres‐Macho, (unknown), (unknown), Chiara Cogliati, Odd Helge Gilja, (unknown), Eleni Karlafti, Michal Kršek, (unknown), (unknown), (unknown), (unknown), (unknown), Nicholas Smallwood, Claudio Tana, (unknown), Fredrik von Wowern, Frank H. Bosch	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact